Sign in
8-K

Current Report

Avalo Therapeutics, Inc. Filed Acc 0001628280-21-006250

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading cerc-20210325.htm…